XML 45 R36.htm IDEA: XBRL DOCUMENT
v3.23.1

STOCKHOLDERS’ EQUITY (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items] |
SCHEDULE OF RESERVED SHARES | SCHEDULE OF RESERVED SHARES
Exercise of issued and future grants of stock options |  |  | 552,561 |
Exercise of stock warrants |  |  | 4,254,766 |
Total |  |  | 4,807,327 |
SCHEDULE OF STOCK OPTION ACTIVITY | The following represents a summary of the options granted to employees and non-employee service providers that were outstanding at March 31, 2023, and changes during the three-month period then ended: SCHEDULE OF STOCK OPTION ACTIVITY
|  | Shares |  |  | Weighted– Average Exercise Price |  |  | Range of Exercise Price |  |  | Weighted– Average Remaining Life (Years) |
Total outstanding – December 31, 2022 |  |  | 608,012 |  |  | $ | 35.02 |  |  | $ | 5.14 - $51.30 |  |  |  | 8.09 |
Granted |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | (55,451 | ) |  |  | 33.05 |  |  |  | 5.14 - 51.30 |  |  |  | — |
Total outstanding – March 31, 2023 |  |  | 552,561 |  |  | $ | 35.22 |  |  | $ | 5.14 — $51.30 |  |  |  | 7.82 |
Exercisable (vested) |  |  | 290,438 |  |  | $ | 46.17 |  |  | $ | 10.50 — $51.30 |  |  |  | 7.35 |
Non-Exercisable (non-vested) |  |  | 262,123 |  |  | $ | 23.08 |  |  | $ | 5.14 - $51.30 |  |  |  | 8.40 |
The following represents a summary of the options granted (under the 2020 Plan and otherwise) to employees and non-employee service providers that were outstanding at March 31, 2022, and changes during the three-month period then ended:
|  | Shares |  |  | Weighted– Average Exercise Price |  |  | Range of Exercise Price |  |  | Weighted– Average Remaining Life (Years) |
Total outstanding – December 31, 2021 |  |  | 484,186 |  |  | $ | 60.70 |  |  | $ | 12.40 — $14,657.50 |  |  |  | 8.52 |
Granted |  |  | 2,500 |  |  |  | 10.50 |  |  |  | 10.50 |  |  |  | 9.79 |
Expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeited |  |  | (283 | ) |  |  | 30.00 |  |  |  | 12.40 - 49.70 |  |  |  | — |
Total outstanding – March 31, 2022 |  |  | 486,403 |  |  | $ | 60.50 |  |  | $ | 10.50 — $14,657.50 |  |  |  | 8.28 |
Exercisable (vested) |  |  | 141,720 |  |  | $ | 108.30 |  |  | $ | 32.90 — $14,657.50 |  |  |  | 7.69 |
Non-Exercisable (non-vested) |  |  | 344,683 |  |  | $ | 40.80 |  |  | $ | 10.50 — $51.30 |  |  |  | 8.57 |
SCHEDULE OF ASSUMPTION USED IN BLACK-SCHOLES OPTION-PRICING METHOD | The material factors incorporated in the Black-Scholes model in estimating the fair value of the options granted for the periods presented were as follows: SCHEDULE OF ASSUMPTION USED IN BLACK-SCHOLES OPTION-PRICING METHOD
|  | For the Three Months Ended March 31, |
|  | 2023 |  |  | 2022 |
Expected dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Expected stock-price volatility |  |  | — |  |  |  | 102 | %
Risk-free interest rate |  |  | — |  |  |  | 1.58% — 1.67 | %
Expected average term of options (in years) |  |  | — |  |  |  | 6.00 |
Stock price |  | $ | — |  |  | $ | 1.05 |
SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE | The Company recorded share-based compensation expense and classified it in the condensed consolidated statements of operations as follows: SCHEDULE OF SHARE-BASED COMPENSATION EXPENSE
|  | 2023 |  |  | 2022 |
|  | For the Three Months Ended March 31, |
|  | 2023 |  |  | 2022 |
General and administrative |  | $ | 203,722 |  |  | $ | 1,113,384 |
Research and development |  |  | 48,504 |  |  |  | 153,782 |
Total |  | $ | 252,226 |  |  | $ | 1,267,166 |
Compensatory Warrant Activity [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
SCHEDULE OF WARRANT ACTIVITY | The following table summarizes the equity classified compensatory warrant activity for the three months ended March 31, 2023: SCHEDULE OF WARRANT ACTIVITY
|  | Common Stock |
|  | Shares |  |  | Weighted– Average Exercise Price |  |  | Range of Exercise Price |  |  | Weighted– Average Remaining Life (Years) |
Total outstanding – December 31, 2022 |  |  | 179,046 |  |  | $ | 9.12 |  |  |  | $1.32 — $25.40 |  |  |  | 1.73 |
Granted to advisor and its designees |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Expired |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Forfeited |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Total outstanding – March 31, 2023 |  |  | 179,046 |  |  | $ | 9.12 |  |  |  | $1.32 — $25.40 |  |  |  | 1.48 |
Exercisable |  |  | 179,046 |  |  | $ | 9.12 |  |  |  | $1.32 — $25.40 |  |  |  | 1.48 |
Non-Exercisable |  |  | — |  |  | $ | — |  |  | $ | — |  |  |  | — |
The following table summarizes the equity classified compensatory warrant activity for the three months ended March 31, 2022:
|  | Common Stock |
|  | Shares |  |  | Weighted– Average Exercise Price |  |  | Range of Exercise Price |  |  | Weighted– Average Remaining Life (Years) |
Total outstanding – December 31, 2021 |  |  | 179,065 |  |  | $ | 15.20 |  |  |  | $11.10 — $25.40 |  |  |  | 2.64 |
Granted to advisor and its designees |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Expired |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Forfeited |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Total outstanding – March 31, 2022 |  |  | 179,065 |  |  | $ | 15.20 |  |  |  | $11.10 — $25.40 |  |  |  | 2.39 |
Exercisable |  |  | 179,065 |  |  | $ | 15.20 |  |  |  | $11.10 — $25.40 |  |  |  | 2.39 |
Non-Exercisable |  |  | — |  |  | $ | — |  |  | $ | — |  |  |  | — |
Non Compensatory Warrant Activity [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
SCHEDULE OF WARRANT ACTIVITY | The following table summarizes the noncompensatory equity classified warrant activity for the three months ended March 31, 2023: SCHEDULE OF WARRANT ACTIVITY
|  | Common Stock |
|  | Shares |  |  | Weighted– Average Exercise Price |  |  | Range of Exercise Price |  |  | Weighted– Average Remaining Life (Years) |
Total outstanding – December 31, 2022 |  |  | 547,003 |  |  | $ | 19.76 |  |  |  | 1.32 - 20.00 |  |  |  | 0.33 |
Legacy Ritter warrants |  |  | — |  |  |  | — |  |  |  | - |  |  |  |  |
Granted |  |  | — |  |  |  | — |  |  |  | - |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Expired |  |  | (320,853 | ) |  |  | 20.00 |  |  |  | 20.00 |  |  |  |  |
Forfeited |  |  | — |  |  |  | — |  |  |  | - |  |  |  |  |
Total outstanding – March 31, 2023 |  |  | 226,150 |  |  | $ | 19.42 |  |  |  | - |  |  |  | - |
Exercisable |  |  | 226,150 |  |  | $ | 19.42 |  |  |  | $1.32 — $20.00 |  |  |  | 0.46 |
Non-Exercisable |  |  | — |  |  | $ | — |  |  | $ | — |  |  |  | — |
The following table summarizes the noncompensatory equity classified warrant activity for the three months ended March 31, 2022:
|  | Common Stock |
|  | Shares |  |  | Weighted– Average Exercise Price |  |  | Range of Exercise Price |  |  | Weighted– Average Remaining Life (Years) |
Total outstanding – December 31, 2021 |  |  | 554,914 |  |  | $ | 20.10 |  |  |  | - |  |  |  |  |
Legacy Ritter warrants |  |  | — |  |  |  | — |  |  |  | - |  |  |  |  |
Granted |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Expired |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Forfeited |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Total outstanding – March 31, 2022 |  |  | 554,914 |  |  | $ | 20.10 |  |  |  |  |  |  |  |  |
Exercisable |  |  | 554,914 |  |  | $ | 20.10 |  |  |  | $11.10 — $37.70 |  |  |  | 1.07 |
Non-Exercisable |  |  | — |  |  | $ | — |  |  | $ | — |  |  |  | — |

X
- Definition Schedule of reserved shares [Table Text Block] + References No definition available. + Details
Name: | QLGN_ScheduleOfReservedSharesTableTextBlock
Namespace Prefix: | QLGN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Summary Of Warrant Activity [Table Text Block] + References No definition available. + Details
Name: | QLGN_SummaryOfWarrantActivityTableTextBlock
Namespace Prefix: | QLGN_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=QLGN_CompensatoryWarrantActivityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=QLGN_NonCompensatoryWarrantActivityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |